Filing Details
- Accession Number:
- 0001140361-16-069489
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-10 17:25:40
- Reporting Period:
- 2016-06-08
- Filing Date:
- 2016-06-10
- Accepted Time:
- 2016-06-10 17:25:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1444380 | Nevro Corp | NVRO | Surgical & Medical Instruments & Apparatus (3841) | 562568057 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1613689 | Rami Elghandour | C/O Nevro Corp. 1800 Bridge Parkway Redwood City CA 94065 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-06-08 | 7,000 | $3.60 | 71,180 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-06-08 | 855 | $75.04 | 70,325 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-06-08 | 5,545 | $76.74 | 64,780 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-06-08 | 600 | $77.45 | 64,180 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2016-06-08 | 7,000 | $0.00 | 7,000 | $3.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 78,051 | 2023-05-14 | No | 4 | M | Direct |
Footnotes
- Includes 63,695 RSUs.
- The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.20, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $76.17 to $77.15, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $77.30 to $77.77, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The option, representing the right to purchase 88,207 shares of the Issuer's common stock, vests and becomes exercisable in respect to 1/48th of the original number of shares subject to the option on each monthly anniversary measured from May 15, 2013 (the "Vesting Commencement Date"), such that 100% of the shares underlying the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.
Billionaire Hedge Funds
